This protocol is judged by an institutional review board, an unbiased team that opinions any medical trials involving people. If a study will involve a Timetable I drug, as soon as the board approves the protocol as ethical, the researchers really need to submit an application for an investigational new drug (IND) variety within the FDA.Many social